Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by MBAon May 06, 2020 7:29pm
369 Views
Post# 30995510

RE:RE:Beacon raised estimate to 15.50 Canadian, was 12.50 Canadian

RE:RE:Beacon raised estimate to 15.50 Canadian, was 12.50 CanadianAnd Cooper's annual EBITDA numbers translate into $1.15 (Canadian) per share.  Core business providing close to $1 per share.  15 x gets you to $15 without the one time product sales.  We now need management to continue to excute and as each quarter plays out, more investors may develop the confidence in the company to give it a 15x multiple.

With his update, Cooper has revised his estimates, now calling for 2020 revenue and EBITDA of $115.0 million and $32.6 million. At the time of publication, his new $15.50 target represents a projected return of 63 per cent.
Bullboard Posts